NCT07261241 2025-12-03NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + DinutuximabNew Approaches to Neuroblastoma Therapy ConsortiumPhase 2 Not yet recruiting118 enrolled